Proficio Capital Partners LLC Takes Position in ICU Medical, Inc. (NASDAQ:ICUI)

Proficio Capital Partners LLC bought a new stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 37,241 shares of the medical instruments supplier’s stock, valued at approximately $5,779,000. Proficio Capital Partners LLC owned about 0.15% of ICU Medical as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. FMR LLC increased its position in ICU Medical by 2,676.6% during the third quarter. FMR LLC now owns 104,094 shares of the medical instruments supplier’s stock valued at $18,968,000 after acquiring an additional 100,345 shares during the last quarter. State Street Corp boosted its stake in shares of ICU Medical by 9.3% during the 3rd quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier’s stock worth $165,384,000 after purchasing an additional 77,506 shares during the period. Geode Capital Management LLC grew its holdings in ICU Medical by 9.6% during the 3rd quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier’s stock valued at $99,687,000 after purchasing an additional 48,106 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in ICU Medical by 10.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 301,107 shares of the medical instruments supplier’s stock worth $54,868,000 after purchasing an additional 27,927 shares during the period. Finally, Principal Financial Group Inc. lifted its stake in ICU Medical by 24.6% in the third quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier’s stock worth $23,130,000 after purchasing an additional 25,031 shares during the last quarter. Hedge funds and other institutional investors own 96.10% of the company’s stock.

ICU Medical Trading Up 2.3 %

Shares of NASDAQ ICUI opened at $143.45 on Monday. ICU Medical, Inc. has a twelve month low of $93.36 and a twelve month high of $196.26. The firm has a market cap of $3.52 billion, a PE ratio of -31.39 and a beta of 0.73. The business has a fifty day simple moving average of $157.27 and a two-hundred day simple moving average of $164.97. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75.

Insiders Place Their Bets

In other news, CEO Vivek Jain sold 1,373 shares of the business’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total value of $213,474.04. Following the completion of the transaction, the chief executive officer now directly owns 104,593 shares of the company’s stock, valued at approximately $16,262,119.64. The trade was a 1.30 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 6.70% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on ICUI. Jefferies Financial Group upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target on the stock in a report on Wednesday, December 11th. StockNews.com lowered ICU Medical from a “buy” rating to a “hold” rating in a research note on Monday, March 10th. Finally, Raymond James set a $97.00 target price on shares of ICU Medical in a research note on Wednesday. Two analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $168.67.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.